⚡A study suggests a blood test may identify Alzheimer's risk up to ten years before symptoms appear.

"A simple blood test could reveal Alzheimer’s risk 10 years before symptoms" — Science Daily (all) · Science & Medicine

31 Oct 2026

What it means

This refers to a blood test that measures specific biomarkers—such as phosphorylated tau (p-tau) proteins—to detect Alzheimer’s disease pathology up to a decade before clinical symptoms emerge. The test is being studied as a screening tool for early intervention, though it is not yet standard clinical practice.

Accuracy & sourcesSourced

The claim is based on a peer-reviewed study, but Science Daily's reporting likely simplifies the findings. The original primary source (e.g., a paper in a medical journal) would provide key specifics on cohort size, biomarker thresholds, and predictive performance; without access, the exact strength of the evidence remains unverified.

How new

Genuinely new—this appears to be coverage of recently published research, not resurfaced older material.

Past coverage

We covered the FDA clearance of Roche and Eli Lilly's Alzheimer's blood test in August 2026, which is a related regulatory milestone for such tests.